Take your ePRO clinical outcome assessments from clunky to convenient. Intuitive, configurable solutions improve the participant experience, site processes, and data quality, from protocol to postmarket.

Unearth the ways electronic clinical outcome assessment technology is revolutionizing data collection, improving patient experiences, and enhancing trial outcomes.

Watch to learn how you can build a better data management and compliance monitoring plan for your COAs in your next DCT trial.

Master protocol design trials require an endless stream of consent forms, adding time, cost, and risk. Learn how a feature-rich eConsent platform can simplify those processes and improve engagement.

While informed consent is a critical process for ensuring participant autonomy, consent forms are too long, unclear, difficult to read, and frequently exceed 9th grade reading levels. Explore why eConsent is a potential solution to this problem.

This on-demand webinar provides a thorough overview of why IQVIA Technologies is building One Home for Sites, how it works, and who should participate.

Take your ePRO clinical outcome assessments from clunky to convenient. Intuitive, configurable solutions improve the participant experience, site processes, and data quality, from protocol to postmarket.

In oncology trials, safety and tolerability are a core focus. From centralized ECGs to patient-reported outcomes, utilize this guide for optimizing assessments of drug safety and quality of life.

With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.